Delivery Order SPE2DB24D9131-SPE2DB24FXRN9
- Not listed
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 1,000 unit vials of the drug KCENTRA. The order, valued at $72,075.36, has an ultimate completion date of June 21, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $18,896.64 contract is for the delivery of 1,000 units of the specialized medication Kcentra by January 8, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $27,408.64 contract is for the delivery of 1,000 unit vials of the medication Kcentra. The order is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,124.80 contract is for the delivery of 1,000 unit vials of the specialized medication Kcentra by August 27, 2024. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,609.92, is for the delivery of 1,000-unit vials of the medication Kcentra, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,284.80, is for the delivery of 1,000 unit vials of the drug Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,740.80, is for the delivery of 500-unit vials of the medication Kcentra. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,388.80 firm fixed-price delivery order is for the supply of 1,000 unit vials of Kcentra, a blood coagulation factor medication, with a performance period through September 18, 2024. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program,...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $71,947.68 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra, with a period of performance through May 2, 2024. The award is issued by the Defense Logistics Agency (DLA), a defense agency that provides supplies and services to the U.S. military. This delivery order is placed against DMS Pharmaceutical Group's...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB24FXRN9Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,655.68 order is for 1,000 unit vials of the drug Kcentra, with a performance period through August 7, 2024. The award is made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products and medical supplies to support the recurring needs of military healthcare facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to the Department of Defense. This order has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 7/17/24 |